Velso™

Therapeutic Segment:
Anti-viral

Generic Name:
Velpatasvir/Sofosbuvir

Description:
VELSO is a fixed-dose combination of sofosbuvir, a hepatitis C virus (HCV) nucleotide analog NS5B polymerase inhibitor, and velpatasvir, an HCV NS5A inhibitor.

Indication:
VELSO Tablets are indicated for the treatment of adult patients with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5, or 6 infections:
• without cirrhosis or with compensated cirrhosis
• with decompensated cirrhosis for use in combination with ribavirin

Formulation:

• Tablets

Strength:

• 100mg/400mg

Pack Size:

• 28’s